Our focus is getting new solutions into the hands of people who need them

New solutions don’t change the world on their own. They must be in the hands of those who need them to truly make an impact. That’s why XPhyto focuses on medical diagnosis and treatment options that are efficient, accessible, producible at scale and easily administered; to help more people around the world experience improved quality of life and better health outcomes.

Innovation Changes Lives

Our work has the potential to impact the lives of those suffering from mental health conditions, epilepsy, addiction and trauma-related stress disorder, to name a few.

Helping Our Global Community

Our products are designed to be accessible and effective to decrease the burden on the healthcare system and support the recovery of key global industries.

Why Research Matters

Exploring the cutting-edge of innovation requires rigorous research and testing to make sure the solutions we design are effective and safe, as well as life-changing.

Impacting People
& Communities

XPhyto Pandemic Management child wearing mask

Impacting Pandemic Management

Our COVID-19 PCR system may help people around the world get rapid diagnostic results.

XPhyto and its exclusive development partner, 3a, are leading the development and production of a rapid, point-of-care PCT test system designed for use with minimal lab equipment and training. This enables deployment in community and industry sites such as pharmacies and airports. 

“With no need for large, specialized laboratories, our system is particularly well suited for point-of-care testing. We believe this will provide increased speed, convenience and flexibility for the immediate identification of infected people in a wider variety of settings through the use of satellite and mobile labs,” says Hugh Rogers, CEO & Director of XPhyto. 

Learn more about our COVID-19 tests

Impacting Mental Health & Addictions

Our psychedelics research has the potential to solve global health challenges

XPhyto believes in the impact psychedelic compounds such as psilocybin (magic mushrooms), mescaline, LSD and MDMA can have in the treatment of depression, anxiety, drug and alcohol addictions, and post-traumatic stress disorder (PTSD). An increasing number of evidence-based scientific studies suggest that these drugs are effective, safe, non-toxic in modest doses and are non-addictive.

“Our initial focus is to develop standardized drug formulations with precise, predictable and efficient delivery of their active pharmaceutical ingredients for clinical study and therapeutic use,” said Dr. Raimar Löbenberg, XPhyto Director and Founder/Director of the Drug Development and Innovation Centre at the University of Alberta. “XPhyto intends to first produce psychedelic active pharmaceutical ingredients (APIs), which can then be incorporated into our novel sublingual and transdermal delivery systems. This is our competitive advantage, from production of API to drug formulation to clinical validation.” 

See our therapeutic products

XPhyto Impact addictions counsellor

Impacting Industry

XPhyto is breaking the mold to make a difference

XPhyto’s model is changing the face of pharmaceuticals.

Our model is, at its core, one of entrepreneurship and collaboration. With an eye for opportunity and a belief that working as a collective drives more impactful change, we are breaking new ground and driving the curve in pharmaceuticals. 

The XPhyto network fosters innovation, accelerates research, and speeds up commercialization to put disruptive technology and products into the hands of those who need them most.

Launch of a rapid PCR diagnostic COVID-19 test that could help to expedite the recovery of many industries, particularly international travel.


Ground-breaking research into CBD and THC oral dissolvable drug formulations for patients suffering from epilepsy and symptoms related to cancer treatment and AIDS.


Psychedelic agreements for the production of psilocybin and mescaline, and R&D of multiple psychedelic compounds for the treatment of mental health-related conditions.

Rapid Delivery and Production

We’re working with world-class life science industry and academic leaders


Scientist looking in magnifying glass XPhyto

Be in the know. Get our press releases and latest news first.

Hear about our latest research, products, exclusive partnerships & more.

Unsubscribe anytime. View our Privacy Policy for additional information.